Yovanni Casablanca, MD
Obstetrics & Gynecology · Charlotte, NCNPI 1326025966
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,703 of the $13,381 with a category attached, or 65.0%. 9 manufacturers reported payments, led by AstraZeneca at 46.9% of the total. Among obstetrics & gynecology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $581.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$6K
- Corcept Therapeutics$4K
- GSK$3K
- Aadi Bioscience, Inc.$239
- AbbVie$208
- Tesaro, Inc.$125
- plus $197 from 3 others
Across 4 payments — averaging $4937.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$18K
- GSK$2K
What the payments were for
- Consulting fees$8,70365%
- Speaking & faculty fees$3,30025%
- Food & beverage$1,31410%
- Education$650%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $6,276 |
| Corcept Therapeutics | 5 | $3,501 |
| GSK | 6 | $2,835 |
| Aadi Bioscience, Inc. | 2 | $239 |
| AbbVie | 2 | $208 |
| Tesaro, Inc. | 1 | $125 |
| Pfizer | 1 | $118 |
| Seagen Inc. | 1 | $43 |
| Intuitive Surgical | 2 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,381 in reported general payments places this provider in the 95th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 13 | $1,303 |
| Imiquimod | 11 | $367 |
| Dexamethasone | 16 | $355 |
| Ondansetron Hcl | 23 | $162 |
| Prochlorperazine Maleate | 15 | $142 |
| Oxycodone Hcl | 17 | $44 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Charlotte
- Jerry MatkinsCharlotte$481K
- Leslie Hansen-LindnerCharlotte$372K
- Shan BiscetteCharlotte$106K
- Melissa WoolworthCharlotte$86K
- Heather BaneCharlotte$50K
- Nita DesaiCharlotte$34K
- Scott SchneiderCharlotte$19K
- Allison PuechlCharlotte$13K
- Smitha VilasagarCharlotte$11K
- Kecia GaitherCharlotte$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.